Symphony Health Names William Nelligan CEO

Symphony Health Solutions, a provider of data, analytics, and technology-based products for life science manufacturers, has named William Nelligan to the post of chief executive. Symphony Health Solutions was formed by the Symphony Technology Group by combining four healthcare companies.


Symphony Health Solutions, a provider of high-value data, analytics, and technology

based solutions for life science manufacturers, payers and providers,

today announced the appointment of William Nelligan as Chief Executive

Officer.  Launched in May, Symphony Health Solutions was formed by the

Symphony Technology Group (STG) by combining four complementary

healthcare insight companies, including AlphaDetail, ImpactRx, Source

Healthcare Analytics and TargetRx, into a customer-centric firm

focused on innovation within the industry.


Nelligan joins Symphony Health Solutions following a successful,

multi-decade career running healthcare information services businesses

first with Thomson Healthcare and then with IMS Health for more than

10 years, where he held multiple positions, including SVP Emerging

Markets, President of Asia Pacific, and most recently President, U.S.

and Americas.


“The mission of Symphony Technology Group is to build great

customer-centric companies that leverage data, analytics and

technology and innovate continuously to maximize the value they

deliver to clients,” said Dr. Romesh Wadhwani, Chairman and CEO of

STG.  “We are building Symphony Health Solutions to serve an industry

that is undergoing dramatic change. As a customer-centric, highly

innovative company we must deliver breakthrough insights and enable

our clients to make strategic decisions faster to achieve maximum

commercial outcomes in this rapidly transforming industry. In this

context, we are delighted that Bill Nelligan has joined Symphony

Health Solutions as CEO.  He knows our industry extremely well, both

in terms of where service providers have succeeded in delivering

value, but also in understanding that the health insights industry has

not kept pace with the changes in this complex and rapidly evolving

healthcare ecosystem. Bill and our entire leadership team have a

passionate commitment to transform our company and industry to meet

the business needs and value expectations of life sciences clients and

to enable value-creating collaboration between life sciences

companies, payers, government and providers.”


“It is clear the healthcare marketplace is undergoing dramatic change,

marked by massive shifts in stakeholder influence on healthcare

decisions, and this creates an enormous opportunity for Symphony

Health Solutions to lead the evolution of the health information

industry,” said Bill Nelligan. “Through the combination of our strong

foundation of capabilities, our clear focus on new market

requirements, and STG’s experience and expertise we will deliver

technology-enabled solutions to innovate the way our clients set

strategy and measure performance. I am enthusiastic about the

challenge and opportunity to advance our business in a critical



Symphony Health Solutions is comprised of Source Healthcare Analytics

and ImpactRx, which recently acquired TargetRx and AlphaDetail. The

businesses will be integrated with a focus on strong joint value

propositions for clients and innovation.  In addition to Bill Nelligan

as CEO, the current management teams of the businesses, Greg Ellis,

President and CEO, ImpactRx; Bob Jansen, President Source Commercial &

GM and Michelle Woker, President Source Operations, will continue in

their respective roles.


About Symphony Health Solutions

Symphony Health Solutions provides comprehensive and multi-dimensional

understanding of relevant information necessary to measure performance

and inform strategies for optimal business decision-making. Focused on

conveying value through information to the life sciences and

healthcare industries, each of its units brings deep sector expertise

and innovation in the delivery of insight to our client partners.


Comprised of AlphaDetail, ImpactRx, Source Healthcare Analytics and

TargetRx, the company connects a broad set of research, analytics and

health information products that together form a leading performance

measurement group. On this strong collaborative platform, Symphony

Health Solutions builds innovative solutions to unite information with

insight, and deliver high-value knowledge products that enable clients

to operate within an evolving healthcare ecosystem.   For more

information, visit:



About Symphony Technology Group

Symphony Technology Group (STG) is a strategic private equity firm

with the mission of investing in and being a partner in building great

software and services companies. In addition to capital, STG provides

transformation expertise to enable its portfolio companies to deliver

more value to clients to retain and attract the best talent, and to

achieve best-in-class business performance. All STG portfolio

companies are expected to grow through innovation. STG’s current

portfolio consists of 15 global companies with combined revenue of

$2.5 Billion, and 15,000 employees spread evenly across North America,

Europe and Asia.